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correlation with the morphology by CARTO/CT/MR existed and to assess its influence
on device implantation difficulty.
Results: Our study demonstrates the existence of 3 different types of LAA ostium take-
off: Type I shows a superior and anterior os take-off, with a wide and short left lateral
ridge (LLR) (53%). Type II shows the ostium is similar to type I but the LLR is long
and narrow, causing the entrance vestibule to the LAA ostium (limbus of the LAA) to
be very well defined (32%). Type III (15%), shows a lower and more posterior LAA
take-off with a sharp separation between the LAA and the left PV ostia; the LAA ostium
hardly shows a limbus and is located very close to the LA floor, making its cannulation
extremely difficult leading to greater complexity in the implantation of the device
(procedure time: 91.6±37.6 vs 119.6±0.57 p:0.015).
Morphological data of the left atrium and type of left atrial appendage
LLR:Left lateral ridge
Conclusion: The use of CARTO/CT/MR could be a useful means of defining different
types of LAA take-offs, which could have prognostic and strategic implications for the
implantation of LAA closure devices.
TCT-720
Percutaneous Closure of the Left Atrial Appendage with the Amplatzer Cardiac
Plug:Initial Latin American Experience
Aníbal Agustín Damonte1, Costantino Costantini2, Marcio Montenegro3, Carlos
Pedra4, Alejandro Martinez5, Fabio Brito6, Jose Condado7, Daniel Aguirre8, Horacio
Faella9, Leon Valdivieso10, Miguel Ballarino11, Alejandro Fernandez12, Fernando
Cura13
1Interventional Cardiology, Instituto Cardiovascular de Rosario, Rosario,
Argentina; 2Hospital Cardiológico Costantini, Curitiba, Brazil; 3Instituto Estadual
de Cardiología, Rio de Janeiro, Brazil; 4Instituto Dante Pazzanese, Sao Paulo,
Brazil; 5Universidad Católica, Santiago, Chile; 6Hospital Albert Einstein, Sao
Paulo, Brazil; 7Hospital Perez Carreño, Caracas, Venezuela; 8Clínica Alemana,
Santiago, Chile; 9FLENI, Buenos Aires, Argentina; 10Fundación Favaloro, Buenos
Aires, Argentina; 11Hospital Privado, Córdoba, Argentina; 12Hospital Italiano,
Buenos Aires, Argentina; 13Instituto Cardiovascular de Buenos Aires, Buenos Aires,
Argentina
Background: Atrial fibrillation (AF)is the most common cardiac arrhythmia and a
major cause of morbidity and mortality secondary to cardioembolic stroke. In patients
with non valvular AF 90% of intracavitary thrombi form in the left atrial appendage
(LAA). Percutaneous closure of the LAA has emerged as a potential alternative to
anticoagulation therapy for the prevention of cerebrovascular events in patients with
AF and a contraindication or difficulties for oral anticoagulation. This study describes
the feasibility and in hospital results of the transcatheter closure of the LAA with the
new Amplatzer Cardiac Plug (ACP) in an initial Latin American experience.
Methods: Physician initiated retrospective registry, including all consecutive patients
with AF at high risk for cardioembolic stroke, from different Latin American hospitals
that were treated with the ACP, from August 2009 to April 2011. The procedures were
performed under general anesthesya, and transesophageal ecocardiography (TEE) and
fluoroscopic guidance.
Results: 40 patients were included. Age 72±8.7 years;male 70%; CHADS2 score
3.15±1.1 LAA neck diameter was 20.3±3.8 mm by TEE and 22.6±3.2 by angiography.
LAA occlusion was attempted and successfully achieved in all 40 patients, and in 2
cases, simultaneous closure of the LAA and PFO was performed. The implanted device
size was 25±2.9 mm. There were serious in hospital complications in 3 patients (7.5%).
1 patient experienced device embolization that required surgical retrieval, and 2 patients
presented serious pericardial effusion. There were not in hospital deaths, stroke, or
myocardial ischemia.
Conclusion: In this initial experience, percutaneous closure of the LAA with the ACP
in patients with AF at high risk of stroke was feasible, with a high technical success,
and a complications rate similar to previous reports with this and other devices during
the learning phase of the procedure.
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Background: Percutaneous left atrial appendage (LAA) occlusion is a novel approach
for stroke propyhaxis in patients with atrial fibrillation (AF) and contraindications for
oral anticoagulation. The Amplatzer Cardiac Plug (ACP) device consists of a lobe
anchored in the LAA with a connected disk shielding the LAA ostium. In 6 patients
postinterventional thrombus formation on the disk was found. We analyzed pre
interventional echo parameters as possible risk factors.
Methods: LAA occlusion was performed in 34 consecutive AF patients (CHADS2
score ≥2) under concious sedation. Post interventional dual antiplatelet therapy was
initiated according to manufacturer’s instructions of use. Transthoracic (TTE) and
transesophageal echo (TEE) were performed pre interventionally, pre discharge, after
3 and 6 months. Ejection fraction (EF), left atrial volume index (LAVi), LAA velocity,
spontaneous echo contrast (SEC, scored 0-4) and transmitral gradient (TMG) were
analyzed.
Results: In 36 procedures 34 ACP were implanted successfully. 2 ACP could not be
placed due to an inappropriate anatomy. Mean occluder size was 24.1 ± 3.1 mm. In 3
patients thrombus was detected in the pre discharge TEE, in 3 further patients after 3
months. Mean EF was 50.6 ± 11.4 % in the non-thrombus vs. 39.7 ± 10.6 % in the
thrombus group (p = 0.039, significant). LAVi was 46.9 ± 20.8 vs. 56.6 ± 14.2 ml/m2
(p = 0.285), LAA velocity was 51.3 ± 25.1 vs. 36.8 ± 17.7 cm/s (p = 0.194), SEC was
1.3 ± 0.9 vs. 1.5 ± 0.5 (p = 0.632) and TMG was 1.9 ± 2.0 vs. 1.4 ±0.5 mmHg (p =
0.568).
Thrombus formation after implantation oft he ACP into the LAA (left 2D, right
RT3D TEE).
Conclusion: Thrombus formation on the new ACP device is a serious complication
that should lead to caution. EF was significantly lower in the thrombus group and could
be therefore identified as a risk factor under the dual antiplatelet regime.
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Background: Closure of the left atrial appendage (LAA) is seen as an attractive
therapeutic option for nonvalvular atrial fibrillation patients with contraindications to
taking oral anticoagulants. Proper device size selection is crucial to ensuring proper
implantation and avoiding multiple attempts which, in turn, increase the risk of
complications. The object of this paper is to present our results and determine the
information that can be contributed by the use of the Carto system using MR or CT
images, with particular emphasis on the aspect of size selection.
Methods: The first 30 patients in our series which underwent implantation of the ACP
device were studied. After the first 5 cases, Carto RM was performed on 10 patients
and Carto CT on the following 15. The measurements obtained by transoesophageal
echocardiography (TEE) and angiography (A) were compared with those obtained by
CARTO/CT/MR (C). The influence of the three techniques on the correct selection of
the final device size was assessed.
Results: In only one case the device could not be implanted and in only three cases it
was necessary to change the final device size selected. There were not cardiac
complications. The superoinferior (SI) axis was usually found to be longer than the
anteroposterior one (in 22 out of 25) (20.3±3.5mm vs 18.02±2.9mm) and in most cases,
it determined device size. In only 33.3% of cases there was found to be agreement
between all three measurement techniques, A, TEE and C, leading to an accurate device
size selection. Measurements using C were definitive for the selection of the ACP
device in 87.5% of cases, versus 75%, for A and 45.8% for TEE. In 20.8% of cases
(5/24) C correctly influenced the change in device size selected using the other
techniques. Moreover, it offered information on the orientation of the LAA, thus
helping to establish the implantation strategy. Mean measurement of implanted ACP
device was 22.26±3.22 mm.
Conclusion: Performing CARTO/CT/MR assists in the implantation of the ACP device
and reduces the need for changing device and, indirectly, potential complications.
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Background: Since the optimal treatment for symptomatic pericardial effusion has
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